Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...
The doctor’s words hit Paul Rivera hard. This wasn’t just a cold; he had pulmonary fibrosis, a progressive condition where the lungs become scarred and unable to send oxygen to the brain and heart.
Idiopathic pulmonary fibrosis stands as one of medicine’s most challenging respiratory conditions, gradually transforming healthy lung tissue into stiff, scarred material that severely compromises ...
All eyes were on Crown Princess Mette-Marit of Norway during an unexpected family reunion on Friday. The nation’s future ...
The Pulmonary Fibrosis Foundation (PFF) today announced its PFF Walk 2026 schedule as the organization celebrates the 10 (th) season of the national fundraising program, which has raised more than $7.
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results